Logo image of ALBKK.PA

BAIKOWSKI SAS (ALBKK.PA) Stock Fundamental Analysis

EPA:ALBKK - Euronext Paris - Matif - FR0013384369 - Common Stock - Currency: EUR

21  0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ALBKK. ALBKK was compared to 69 industry peers in the Chemicals industry. ALBKK has an excellent financial health rating, but there are some minor concerns on its profitability. ALBKK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ALBKK had positive earnings in the past year.
In the past year ALBKK had a positive cash flow from operations.
ALBKK had positive earnings in each of the past 5 years.
In the past 5 years ALBKK always reported a positive cash flow from operatings.
ALBKK.PA Yearly Net Income VS EBIT VS OCF VS FCFALBKK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M 10M

1.2 Ratios

ALBKK has a better Return On Assets (5.47%) than 73.53% of its industry peers.
ALBKK's Return On Equity of 8.28% is fine compared to the rest of the industry. ALBKK outperforms 61.76% of its industry peers.
ALBKK has a Return On Invested Capital of 3.85%. This is comparable to the rest of the industry: ALBKK outperforms 58.82% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALBKK is below the industry average of 6.84%.
Industry RankSector Rank
ROA 5.47%
ROE 8.28%
ROIC 3.85%
ROA(3y)5.5%
ROA(5y)5.78%
ROE(3y)8.43%
ROE(5y)9.14%
ROIC(3y)4.4%
ROIC(5y)4.46%
ALBKK.PA Yearly ROA, ROE, ROICALBKK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 7.95%, ALBKK is doing good in the industry, outperforming 73.53% of the companies in the same industry.
In the last couple of years the Profit Margin of ALBKK has grown nicely.
The Operating Margin of ALBKK (6.12%) is comparable to the rest of the industry.
ALBKK's Operating Margin has been stable in the last couple of years.
ALBKK's Gross Margin of 58.07% is amongst the best of the industry. ALBKK outperforms 88.24% of its industry peers.
In the last couple of years the Gross Margin of ALBKK has remained more or less at the same level.
Industry RankSector Rank
OM 6.12%
PM (TTM) 7.95%
GM 58.07%
OM growth 3Y-22.94%
OM growth 5Y-0.34%
PM growth 3Y-19.29%
PM growth 5Y4.18%
GM growth 3Y-5.48%
GM growth 5Y-1.45%
ALBKK.PA Yearly Profit, Operating, Gross MarginsALBKK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALBKK is destroying value.
ALBKK has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ALBKK remains at a similar level compared to 5 years ago.
Compared to 1 year ago, ALBKK has an improved debt to assets ratio.
ALBKK.PA Yearly Shares OutstandingALBKK.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALBKK.PA Yearly Total Debt VS Total AssetsALBKK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.91 indicates that ALBKK is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.91, ALBKK belongs to the top of the industry, outperforming 83.82% of the companies in the same industry.
The Debt to FCF ratio of ALBKK is 5.76, which is a neutral value as it means it would take ALBKK, 5.76 years of fcf income to pay off all of its debts.
ALBKK has a Debt to FCF ratio of 5.76. This is in the better half of the industry: ALBKK outperforms 69.12% of its industry peers.
ALBKK has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.18, ALBKK is in the better half of the industry, outperforming 73.53% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.76
Altman-Z 3.91
ROIC/WACC0.55
WACC6.96%
ALBKK.PA Yearly LT Debt VS Equity VS FCFALBKK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 2.23 indicates that ALBKK has no problem at all paying its short term obligations.
ALBKK has a Current ratio of 2.23. This is in the better half of the industry: ALBKK outperforms 72.06% of its industry peers.
A Quick Ratio of 1.24 indicates that ALBKK should not have too much problems paying its short term obligations.
The Quick ratio of ALBKK (1.24) is better than 60.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.24
ALBKK.PA Yearly Current Assets VS Current LiabilitesALBKK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 313.58% over the past year.
ALBKK shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.64% yearly.
ALBKK shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.61%.
ALBKK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.34% yearly.
EPS 1Y (TTM)313.58%
EPS 3Y-17.66%
EPS 5Y7.64%
EPS Q2Q%207.77%
Revenue 1Y (TTM)32.61%
Revenue growth 3Y2.06%
Revenue growth 5Y3.34%
Sales Q2Q%66.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBKK.PA Yearly Revenue VS EstimatesALBKK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.39, which indicates a rather expensive current valuation of ALBKK.
Compared to the rest of the industry, the Price/Earnings ratio of ALBKK indicates a somewhat cheap valuation: ALBKK is cheaper than 64.71% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.51, ALBKK is valued a bit cheaper.
Industry RankSector Rank
PE 20.39
Fwd PE N/A
ALBKK.PA Price Earnings VS Forward Price EarningsALBKK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

ALBKK's Enterprise Value to EBITDA ratio is in line with the industry average.
ALBKK's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 33.25
EV/EBITDA 12.86
ALBKK.PA Per share dataALBKK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

ALBKK has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.67
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

ALBKK has a Yearly Dividend Yield of 1.43%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.05, ALBKK has a dividend in line with its industry peers.
With a Dividend Yield of 1.43, ALBKK pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.43%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALBKK.PA Yearly Dividends per shareALBKK.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
ALBKK.PA Yearly Income VS Free CF VS DividendALBKK.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

More info and screens

BAIKOWSKI SAS

EPA:ALBKK (8/8/2025, 7:00:00 PM)

21

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners9.15%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap77.28M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.43%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.39
Fwd PE N/A
P/S 1.62
P/FCF 33.25
P/OCF 11.79
P/B 1.69
P/tB 1.96
EV/EBITDA 12.86
EPS(TTM)1.03
EY4.9%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.63
FCFY3.01%
OCF(TTM)1.78
OCFY8.48%
SpS12.96
BVpS12.44
TBVpS10.7
PEG (NY)N/A
PEG (5Y)2.67
Profitability
Industry RankSector Rank
ROA 5.47%
ROE 8.28%
ROCE 5.24%
ROIC 3.85%
ROICexc 4.28%
ROICexgc 4.9%
OM 6.12%
PM (TTM) 7.95%
GM 58.07%
FCFM 4.87%
ROA(3y)5.5%
ROA(5y)5.78%
ROE(3y)8.43%
ROE(5y)9.14%
ROIC(3y)4.4%
ROIC(5y)4.46%
ROICexc(3y)5.21%
ROICexc(5y)5.32%
ROICexgc(3y)6.11%
ROICexgc(5y)6.27%
ROCE(3y)5.99%
ROCE(5y)6.08%
ROICexcg growth 3Y-24.8%
ROICexcg growth 5Y2.36%
ROICexc growth 3Y-24.04%
ROICexc growth 5Y2.87%
OM growth 3Y-22.94%
OM growth 5Y-0.34%
PM growth 3Y-19.29%
PM growth 5Y4.18%
GM growth 3Y-5.48%
GM growth 5Y-1.45%
F-Score6
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.76
Debt/EBITDA 1.27
Cap/Depr 114.24%
Cap/Sales 8.87%
Interest Coverage 7.08
Cash Conversion 99.02%
Profit Quality 61.34%
Current Ratio 2.23
Quick Ratio 1.24
Altman-Z 3.91
F-Score6
WACC6.96%
ROIC/WACC0.55
Cap/Depr(3y)92.13%
Cap/Depr(5y)70.79%
Cap/Sales(3y)7.58%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)313.58%
EPS 3Y-17.66%
EPS 5Y7.64%
EPS Q2Q%207.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.61%
Revenue growth 3Y2.06%
Revenue growth 5Y3.34%
Sales Q2Q%66.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9306.45%
EBIT growth 3Y-21.36%
EBIT growth 5Y2.99%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y196.59%
FCF growth 3Y-35.63%
FCF growth 5YN/A
OCF growth 1Y735.71%
OCF growth 3Y-14.23%
OCF growth 5Y51.06%